Browse diseases

…setting of established metabolic disorders, such as obesity and type 2 diabetes mellitus. MASLD is a complex and multifactorial condition for which nume…

…OEP and MASLD, with enrichment analysis pointing to pathways in non-alcoholic fatty liver disease and insulin resistance. PPI analysis highlighted ACTB, IL6, PPA…

…ing an elevated FIB-4, identified patient subgroups with annual hepatocellular carcinoma (HCC) incidence ≥1%, justifying surveillance in these groups.1 …

…ver-related events and all-cause mortality but a lower risk for cardiovascular disease than their non-lean counterparts. Their analyses on diverse adv…

…Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is a leading chronic liver disorder closely linked to diabetes …

…SLD) is rapidly increasing with high risk to develop cirrhosis, hepatocellular carcinoma (HCC) and other end-stage liver diseases. However, only two dru…

…Objectives Metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent chronic condition often accompanied by multiple …

…olic dysfunction-associated steatotic liver disease (MASLD) and gestational diabetes mellitus (GDM) are prevalent metabolic disorders in pregnancy, posing signific…

…3 4 Given the critical importance of non-invasive assessment of liver fibrosis for the clinical management of CHB,5 we evaluated the predictiv…

…eir interest in our recent study on statin use in patients with metabolic dysfunction-associated steatotic liver disease (MASLD).1 2 Their letter raises several thoughtful concerns about the s…

…Background and study aim Metabolic dysfunction-associated steatotic liver disease (MASLD) is a common metabolic and liver condition that leads to systemi…

… in SAFE score corresponded to a 0.05-point increase in 10-year ASCVD risk, B=0.05, SE=0.005, p<0.001 (figure 1D). The findings sugge…